The sp2-iminosugar glycolipid 1-dodecylsulfonyl-5N, 6O-oxomethylidenenojirimycin (DSO2-ONJ) as selective anti-inflammatory agent by modulation of hemeoxygenase-1 in Bv.2 microglial cells and retinal explants. (January 2018)